The relationship between the acute cerebral metabolic response to citalopram and chronic citalopram treatment outcome

American Journal of Geriatric Psychiatry

Volumn 19, Issue 1, 2011, Pages 53-63

  Smith, Gwenn S ^a,b,e   Workman, Clifford I ^a   Kramer, Elisse ^c,d   Hermann, Carol R ^c,d   Ginsberg, Rachel ^c,d   Ma, Yilong ^e   Dhawan, Vijay ^e   Chaly, Thomas ^e   Eidelberg, David ^e  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Zucker Hill Side Hospitel ^*  (United States)

^c ZUCKER HILLSIDE HOSPITAL   (United States)

^d FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^e Department of Surgery   (United States)

Author keywords

antidepressant; biomarker; citalopram; Depression; geriatric; glucose metabolism; PET; treatment response

Indexed keywords

CITALOPRAM; PLACEBO;

AGED; ANTERIOR CINGULATE; ARTICLE; BRAIN METABOLISM; CAUDATE NUCLEUS; CLINICAL ARTICLE; DEPRESSION; FEMALE; GLUCOSE METABOLISM; HAMILTON SCALE; HUMAN; INFERIOR FRONTAL GYRUS; INFERIOR PARIETAL LOBULE; INSULA; MALE; MIDDLE FRONTAL GYRUS; PARAHIPPOCAMPAL GYRUS; PRECUNEUS; PUTAMEN; SINGLE DRUG DOSE; SUPERIOR FRONTAL GYRUS; TREATMENT OUTCOME;

EID: 78650781693     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1097/JGP.0b013e3181eafde4     Document Type: Article

References (40)

1. Smith GS, Reynolds CF, Houck PR, et al: Glucose metabolic response to total sleep deprivation, recovery sleep, and acute an-tidepressant treatment as functional neuroanatomic correlates of treatment outcome in geriatric depression. Am J Geriatr Psychiatry 2002; 10:561-567
2. Lahti AC, Weiler MA, Holcomb HH, et al: Modulation of limbic circuitry predicts treatment response to antipsychotic medication: a functional imaging study in schizophrenia. Neuropsychopharm 2009; 34:2675-2690
3. Wolkin A, Barouche F, Wolf AP, et al: Dopamine blockade and clinical response: evidence for two biological subgroups of schizophrenia. Am J Psychiatry 1989; 146:905-908
4. Meyer JH, Wilson AA, Ginovart N, et al: Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a [(11)C]DASB PET imaging study. Am J Psychiatry 2001; 158:1843-1849
5. Smith GS, Gunning-Dixon FM, Lotrich FE, et al: Translational research in late-life mood disorders: implications for future intervention and prevention research. Neuropsychopharm 2007; 32: 1857-1875
6. Dew MA, Reynolds CF, Houck PR, et al: Temporal profiles of the course of depression during treatment. Predictors of pathways toward recovery in the elderly. Arch Gen Psychiatry 1997; 54: 1016-1024
7. Wu E, Greenberg P, Yang E, et al: Comparison of treatment persistence, hospital utilization and costs among major depressive disorder geriatric patients treated with escitalopram versus other SSRI/SNRI antidepressants. Curr Med Res Opin 2008; 24: 2805-2813
8. Gunning FM, Cheng J, Murphy CF, et al: Anterior cingulate cortical volumes and treatment remission of geriatric depression. Int J Geriatr Psychiat 2009; 24:829-836
9. Chen PS, McQuoid DR, Payne ME, et al: White matter and sub-cortical gray matter lesion volume changes and late-life depression outcome: A 4-year magnetic resonance imaging study. Int Psychogeriatr 2006; 18:445-456
10. Alexopoulos GS, Murphy CF, Gunning-Dixon FM, et al: Micro-structural white matter abnormalities and remission of geriatric depression. Am J Psychiat 2008; 165:238-244
11. Murphy GM, Hollander SB, Rodrigues HE, et al: Effects of the serotonin transporter gene promoter polymorphism on mirtaza-pine and paroxetine efficacy and adverse events in geriatric major depression. Arch Gen Psychiat 2004; 61:1163-1169
12. Smith GS, Kramer E, Ma Y, et al: The functional neu-roanatomy of geriatric depression. Int J Geriatr Psychiat 2009; 24: 798-808
13. Folstein M, Folstein S, McHugh P: Mini-mental state. J Psych Res 1976; 12:189-198
14. Smith GS, Kramer E, Hermann C, et al: Serotonin Modulation of Cerebral Glucose Metabolism in Geriatric Depression. Am J Geriatr Psychiatry 2003;10, 715-723
15. Smith GS, Kramer E, Hermann C, et al: Serotonin modulation of cerebral glucose metabolism in depressed older adults. Biol Psychiatry 2009; 66:259-266
16. First M, Spitzer R, Gibbon M, et al: Structured Clinical Interview for DSM-IV Axis 1 Disorders-Patient Edition (SCIP-I/P). NY, Psychiatric Institute, 1995
17. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62
18. Beck AT, Steer RA, Ball R, et al: Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. J Pers Assess 1996; 67:588-597
19. Yesavage JA: Geriatric Depression Scale. Psychopharmacol Bull 1988; 24:709-711
20. Smith GS, Ma Y, Dhawan V, et al: Serotonin modulation of cerebral glucose metabolism measured with positron emission tomography (PET) in human subjects. Synapse 2002; 45:105-112
21. Guy W: ECDEU: an assessment manual for psychopharmacology. US Department of Health Education and Welfare Publication (ADM). 1976; 76:336
22. Friston KJ, Ashburner JT, Kiebel SJ, et al (Eds.): Statistical Parametric Mapping: The Analysis of Functional Brain Images. London, Academic Press, 2007
23. Sakai Y, Nishikawa M, Leyton M, et al: Cortical trapping of alpha-[(11)C]methyl-l-tryptophan, an index of serotonin synthesis, is lower in females than males. Neuroimage 2006; 33:815-824
24. Piccinelli M, Wilkinson G: Gender differences in depression. Crit Rev Br J Psychiatry 2000; 177:486-492
25. 11 C]DASB in healthy controls. J Cereb Blood Flow Metab 2008; 28:1478-1490
26. Smith GS, Ma Y, Dhawan V, et al: Selective Serotonin Reup-take Inhibitor (SSRI) modulation of striatal dopamine measured with [11C]-raclopride and positron emission tomography (PET). Synapse 2009; 63:1-6
27. 1D receptors. Br J Pharmacol 2009; 123:45-50
28. Magistretti PJ: Neuronglia metabolic coupling and plasticity. J Exp Biol 2006; 209:2304-2311
29. Buckner RL, Snyder AZ, Shannon BJ, et al: Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory. J Neurosci 2005; 25:7709-7717
30. Peters O, Schipke CG, Philipps A, et al: Astrocyte function is modified by Alzheimer's disease-like pathology in aged mice. J Alzheimers Dis 2009; 18:177-189
31. Golembiowska K, Dziubina A: Effect of acute and chronic administration of citalopram on glutamate and aspartate release in the rat prefrontal cortex. Polish J Pharmacol 2000; 52:441-448
32. Konarski JZ, Kennedy SH, Segal ZV, et al: Predictors of nonre-sponse to cognitive behavioural therapy or venlafaxine using glucose metabolism in major depressive disorder. J Psychiatry Neurosci 2009; 34:175-180
33. Milak MS, Parsey RV, Lee L, et al: Pretreatment regional brain glucose uptake in the midbrain on PET may predict remission from a major depressive episode after three months of treatment. Psychiatry Res 2009; 173:63-70
34. Mayberg HS, Brannan SK, Mahurin RK, et al: Cingulate function in depression: a potential predictor of treatment response. Neuro-report 1997; 8:1057-1061
35. Saxena S, Brody AL, Ho ML, et al: Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disorder versus major depression. Am J Psychiatry 2003; 160: 522-532
36. Renshaw PF, Parow AM, Hirashima F, et al: Multinuclear magnetic resonance spectroscopy studies of brain purines in major depression. Am J Psychiatry 2001; 158:2048-2055
37. Iosifescu DV, Bolo NR, Nierenberg AA, et al: Brain bioenergetics and response to triiodothyronine augmentation in major depressive disorder. Biol Psychiatry 2008; 63:1127-1134
38. Parsey RV, Olvet DM, Oquendo MA, et al: Higher 5-HT1A receptor binding potential during a major depressive episode predicts poor treatment response: Preliminary data from a naturalistic study. Neuropsychopharm 2006; 31:1745-1749
39. Miller JM, Oquendo MA, Ogden RT, et al: Serotonin transporter binding as a possible predictor of one-year remission in major depressive disorder. J Psychiatr Res 2008; 42: 1137-1144
40. Varn̈as K, Halldin C, Hall H: Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain. Hum Brain Mapp 2004; 22:246-260